Preparation and Characterization of Calcium-Incorporated <i>Rosa roxburghii</i> Tratt and Its Efficacy on Bone Mineral Density in Rats

Yan, Yanfang; Luo, Zhongsheng; He, Leilei; Wei, Fuxiao; Gao, Ming; Cui, Xiaofang; Yang, Juan; Sun, Yichun; Li, Lilang; Yang, Lishou; Deng, Tingfei; Pan, Xiong; Peng, Mei; Tan, Yunfei; An, Zhengbin; Li, Liangqun; Yang, Xiaosheng

doi:https://doi.org/10.1155/2022/5122396

Evidence-Based Complementary and Alternative Medicine

On this page

Abstract Introduction Materials and Methods Results and Discussion Conclusion Data Availability Ethical Approval Conflicts of Interest Authors’ Contributions Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2022 | Article ID 5122396 | https://doi.org/10.1155/2022/5122396

Preparation and Characterization of Calcium-Incorporated Rosa roxburghii Tratt and Its Efficacy on Bone Mineral Density in Rats

Yanfang Yan,^1,2Zhongsheng Luo,^1,2Leilei He,^1,2Fuxiao Wei,^1,2Ming Gao,^1,2Xiaofang Cui,³Juan Yang,^1,2Yichun Sun,⁴Lilang Li,^1,2Lishou Yang,^1,2Tingfei Deng,^1,2and Xiong Pan^1,2 et al.

Academic Editor: Carmen Mannucci

Received08 Nov 2021

Accepted16 Mar 2022

Published20 Apr 2022

Abstract

The deficiency of traditional calcium preparation will gradually be replaced by the new type of calcium preparation. Rosa roxburghii fruit (R. roxburghii) is popular for its rich nutrients and functional ingredients. The fermentation broth of R. roxburghii, involving amino acids, flavonoids, triterpenes, polysaccharides, and other compounds, is favorable for calcium chelation. Thus, this study fabricated calcium-incorporated R. roxburghii (FECa) and further illustrated its efficacy on bone mineral density (BMD) in rats. The calcium holding capacity of FECa was identified and confirmed using AAS. Ion complexation of FECa was characterized using ¹H-NMR, UV, SEM and EDS, and FTIR. The calcium contents of femurs were increased by 36%, and the bone trabeculae of femurs were significantly increased. Net calcium balance was enhanced to further improve BMD by oral administration of FECa. The above results indicate that FECa can be a potential and efficient calcium supplementation agent.

1. Introduction

It is well recognized that calcium plays an important role in mammals. Calcium, accounting for approximately 1.5–2.2% of body weight, is a necessary major element in the human body. Approximately, 99% of calcium is in the bone and plays a key role in maintaining bone strength [1, 2]. Moreover, a wide range of biological functions of calcium have been found, such as muscle contraction and nerve impulse transmission [3]. However, calcium deficiency has already become a worldwide nutritional deficiency public health problem [4]. An appropriate amount intake of calcium is indispensable for human health. Recent studies have shown that the concentration of intracellular calcium ions can affect osteoporosis, involving proliferating osteoblasts and chondrocytes. Its mechanism is to promote mineralization and bone formation by activating CaV 1.2 L-type voltage-gated Ca²⁺ induces calcium ion influx, raising the intracellular calcium ion level [5, 6]. Osteoporosis is a metabolic bone disease that can induce calcium loss, and over 200 million people have been suffering from this disease [7, 8]. Efficacy in preventing steroid-induced osteonecrosis of traditional Chinese medicine (TCM) and ethnic medicine-derived herbs or compounds in rats has been reported [9]. For example, Xian Ling Gu Bao Fufang, a famous herbal ethnic medicine formula capsule of Guizhou, has been approved by the China Food and Drug Administration (China, Z20025337) [10].

Rosa roxburghii Tratt (R. roxburghii), belonging to the Rosaceae family, has high edible and medicinal value as a source of homologous medicine and food [11]. R. roxburghii is popular for its rich nutrients and functional ingredients. According to the record of the “Guizhou Tong Zhi,” the fruit of R. roxburghii has been historically used for 380 years as an ancient Chinese medicine for the treatment of different diseases [12]. R. roxburghii fruit is consumed in the clinic to strengthen the spleen and exert antidiarrheal and astringent effects. Accounting for its bioactive functional factors, R. roxburghii fruit has been widely applied and is one of the bulk resources in Guizhou, China; meanwhile, fermentation processing is one of the worth options for long-term storage and utilization of its fruit [13]. Products of fermented fruit have been included in the human diet and have been the most fundamental food; these foods also exhibit many healing properties and could prevent many diseases [14, 15].

The fermentation broth of R. roxburghii, containing amino acids, flavonoids, triterpenes, polysaccharides and other compounds, is favorable for calcium chelation, according to our preliminary experiment [16]. The deficiency of traditional calcium preparation will gradually be replaced by the new types of calcium preparation. Due to the good solubility and body absorption of organic calcium, this study fabricated calcium-incorporated FECa and further illustrated its efficacy on bone mineral density (BMD) in rats. Thus, this study optimized the preparation of calcium-incorporated R. roxburghii (FECa) to further illustrate its characterization and evaluate the efficacy on bone mineral density (BMD) in low-calcium diet-fed SD rats. This work supports the innovative use of R. roxburghii for calcium supplement.

2. Materials and Methods

2.1. Materials

Chromatographic grade methanol and acetonitrile were purchased from Merck (Darmstadt, Germany). Other reagents used were of analytical grade, and guaranteed reagents were all supplied by Tianjin Kemiou Chemical Reagent Co., Ltd. (Tianjin, China). Standard solutions were prepared from 1000 mg/l calcium single-element standard solution (National Center of Analysis and Testing for Nonferrous Metals and Electronic Materials, Beijing, China, GSB 04-1720-2004).

2.2. Preparation of FE and FECa

R. roxburghii Tratt was collected from Guizhou Province, and fresh fruit was collected in September 2019 (voucher specimen number: CL201901). All samples were authenticated by Prof. Qingwen Sun, Guizhou University of Traditional Chinese Medicine. Jiu Qu (commercially available and containing yeasts and enzymes in the specification) was purchased from Guizhou Brewing Engineering Technology Development Center, Guizhou Keli Industrial Co., Ltd. (Guiyang, China) (batch number: q-qk05-2018).

One kilogram of fresh R. roxburghii Tratt fruits was washed and cut into small pieces (thickness of approximately 0.1 cm). Twice the amount of sterilized distilled water was added to beat for one minute by a homogenizer. R. roxburghii Tratt fruit pulp was treated with 0.5% Jiu Qu and 0.2% pectinase along with adding 10% white sugar according to the slurry quality into a sterilized triangular flask and incubated at a temperature of 35°C in a shaker incubator at 120 rpm for 20 days.

FECa was made, and the procedures mainly involved two main steps, including the reaction of R. roxburghii Tratt fruit fermentation (FE) and CaCO₃ and the removal of CaCO₃. Different amounts of CaCO_3, including 0.2002 g, 0.3005 g, 0.4010 g, 0.5009 g, and 1.0013 g CaCO_3, were added to FE liquid (20 mL) and reacted for 24 h. The mixture was centrifuged at 5000∼ 6000 rpm for 10 min, and the supernatant was collected. The FECa and FE dryness samples were obtained by freeze-drying.

2.3. Determination of Calcium Holding Capacity

The calcium content of the FECa sample was determined by flame atomic absorption spectrometry (Agilent, 240FS-240Z, Agilent Technologies Inc., CA, USA) to determine the calcium holding capacity of FECa.

2.4. Characterization of FECa

The surface morphology of the FECa and FE samples was observed by scanning electron microscopy (SEM, ZEISS Gemini 300, USA). Dried samples of FECa and FE were coated with gold to improve their electrical conductivity and thermal stability. SEM observation was performed under the condition of accelerating voltage at 25 kV with a magnification of 200× and 10000×. The surface chemical composition of FECa and FE was examined by energy dispersive spectroscopy (EDS, JEM-2100, JEOL, Ltd., Japan).

2.5. FTIR, ¹H-NMR, and UV Spectroscopy

A Fourier-transform infrared (FTIR) spectrometer (iCAN9, Tianjin spectroscopy Technology Co., Ltd., China) was used to record the FTIR spectra of FE, FECa, CaCO_3, and FE + CaCO₃. The background spectrum of the KBr pellet was subtracted from the FTIR spectra. Dried samples of FE and FECa mixed with KBr (1 : 200) were ground and pressed into a 1 mm pellet. FTIR analysis was conducted in the frequency range from 400 to 4000 cm⁻¹ with transmission mode at a resolution of 4 cm⁻¹.

¹H-NMR spectra of FE and FECa samples were recorded on a Bruker spectrometer (Bruker AMX600 WB, Switzerland). FE and FECa samples were prepared by dissolving the product (25 mg) in 1 ml deuterated water (99.99%).

UV spectra of FECa and FE solutions (2 mg/mL⁻¹) were recorded by spectroscopy on a Cary-60 spectrometer (Agilent Technologies Inc., CA, USA) in the wavelength range of 190 to 600 nm.

2.6. Evaluation of FECa on BMD in SD Rats

2.6.1. Animals and Animal Treatment

For all experiments, 4-week-old male Sprague–Dawley (SD) rats weighing 60–80 g (purchased from SPF (Beijing) Biotechnology Co., Ltd., SCXK (Beijing) 2021–0009) were used. According to the international rules for animal experiments and guidelines for the appropriate use of experimental animals (NIH publication no. 80–23; revised 1978). The acclimatization at a temperature of 23 ± 2°C in the SD rats was performed for at least 1 week before the experiments with free access to water and standard food. All the study protocols were performed according to the international rules for animal experiments and approved by the Animal Ethics Committee of Guizhou Medical University (clearance no. 2000882).

Seventy SD rats were randomly divided into 7 groups (n = 10 in each group): normal control group (NC), model control group (MC), low (L), middle (M), high (H), CaCO₃ group, and calcium gluconate group (CG). The NC group and MC group were administered 0.5% sodium carboxymethyl cellulose, L was administered FECa equal to 20 mg/kg calcium, M was administered FECa equal to 40 mg/kg calcium, H was administered FECa equal to 60 mg/kg calcium, the CaCO₃ group was administered CaCO₃ equal to 40 mg/kg calcium suspended with 0.5% sodium carboxymethyl cellulose, and the CG group was administered calcium gluconate equal to 40 mg/kg calcium. The NC group was fed a normal diet, and the L, M, H, CaCO₃ and CG groups were administered a low-calcium diet (calcium content ≤150 mg/kg). All the rats were treated with gavage for 28 days. Before sacrifice, all SD rats were individually placed into metabolic cages for collection of 24 h urine and feces. The day after the last dose, the rats were euthanized. Blood and femurs were harvested immediately for further analysis.

2.7. Sample Collection

During the experiment, body weight and the amounts of urine and feces were recorded daily. In the last two days, 24 urine and fecal samples were collected. After the 4-week treatment, all SD rats were fasted for 12 hours before being anesthetized and sacrificed and dissected to obtain blood and femur specimens. The residual muscle of the left and right femurs of each rat was cleaned. The left femoral bone samples were intended for bone densitometry, and samples of right femoral bone were stored in 4% paraformaldehyde for histopathological analysis.

2.8. Alkaline Phosphatase (ALP), Serum Calcium, and Serum Phosphorus (P) Expression Assay

Rat blood samples were centrifuged at 3500 rpm for 10 min to obtain the serum. The ALP content in the serum, serum calcium, and serum P were determined. ALP was quantitatively assayed using an ALP detection kit (Nanjing Jiancheng Bioengineering Co., Ltd., China). Serum calcium and serum phosphorus were measured using kits (Nanjing Jiancheng Bioengineering Co., Ltd., China) according to a protocol specified by the manufacturer. Serum calcium was measured through the methyl thymol blue method. The OD was determined at a wavelength of 610 nm.

2.9. Calcium Balance Study

The calcium content of feces and urine samples from SD rats was determined [16]. The following equations were used to calculate the calcium absorption rate and calcium balance:

Ca absorption rate (%) = (Ca intake − fecal Ca)/Ca intake × 100 (1).

Ca balance = Ca intake − (urinary Ca + fecal Ca) (2).

2.10. Femur Condition Detection

The length and wet weight of the bilateral femur bones were recorded. The left femurs were calcined in a muffle furnace at 600°C for 8 h, and the remaining weight was recorded as the dry weight. BMD was measured by using dual-energy X-ray absorptiometry with a bone densitometer (GE Healthcare, USA).

2.11. Bone Mineralization Assay

A calibration standard solution of calcium (GSB 04-1720-2004, National Nonferrous Metals and Electronic Materials Analysis and Testing Center, China) was used. HCl (1 ml, 6 mol/L) was added to dissolve the ashes (0.1 g) of the left femur. Then, a 10 µl solution of the left femur was used to detect the calcium content. The phosphorus content in the femurs was detected by inorganic calcium and phosphorus assay kits (Jiancheng Bioengineering Co., Ltd., China).

2.12. Histopathology Observation

Thigh bone weight was weighed, measured, and conventionally fixed in 10% formalin at 4°C overnight. All femur samples were decalcified for 24 h in an 8% formic acid/hydrochloric acid solution. After the brief water wash, femurs were transferred to ammonia solution to neutralize acids and left to stand for 30 min. Tissues were processed in an automated tissue processor for dehydration and clearing. After dehydration in an ethanol series, the samples were embedded in paraffin, and sections (4 µm) were made. Strips of tissue were stained with hematoxylin and eosin (HE) for morphological evaluation. Then, all the sections were dehydrated with graded ethanol and xylene. The slides (n = 10) were examined under a light microscope (OlympusCorp., Tokyo, Japan) using 400× magnification.

2.13. Statistical Analysis

Statistical analyses were performed by using the SPSS 8.0 software. Data are expressed as the means ± S.D. The level of significance was set at .

3. Results and Discussion

3.1. The Fabrication of FECa

Different amounts of CaCO₃ were added to the FE solution to obtain the optimal synthesis ratio of FE and calcium ions. The increase in the calcium holding capacity of FECa is observed with increasing CaCO₃ amount, and the calcium holding capacity of FECa reaches 16.85% (shown in Figure 1) when the addition of CaCO₃ is 0.4 g. No significant changes are shown in the calcium holding capacity of FECa () when continuing to increase the amount of CaCO₃.

3.2. Morphological Analysis of FECa

SEM and EDS were conducted to determine the morphology and elemental composition of FECa [17]. Compared with FE, the morphology of FECa is rougher with many irregular particles.

The composition and distribution of elements of FE and FECa were detected by EDS. The EDS spectra of FE and FECa (shown in Figure 2(a) and 2(b)) show that the contents of oxygen (O) and calcium in FE are different from those in FECa. Oxygen changes little, and calcium changes greatly, which may be due to the hydrogen in calcium and hydroxyl groups. Combined with the figure, it can be seen that looking at the appearance of the sample and the composition of surface elements, it is found that the differences in oxygen and calcium content between FE and FECa corresponding with the SEM results showed that the fermented R. roxburghii Tratt had a coupling reaction with CaCO_3.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

3.3. FTIR, ¹H-NMR, and UV Spectroscopy

The FTIR, ¹H-NMR, and UV spectroscopy of FE and FECa were recorded to determine the binding site of calcium ions [17–20].

The wavenumbers of FE, FECa, FE + CaCO₃, and CaCO₃ were recorded from 4000 to 400 cm⁻¹. The spectra of FE and FE + CaCO₃ are largely similar, while those of FE and FECa exhibit some differences (shown in Figure 2(e)). The strong absorption band at approximately 3400 cm⁻¹, corresponding to the stretching of –OH and N-H, is observed in the FTIR spectra analysis of FE and FECa. The spectral band at approximately 2930 cm⁻¹ represents the C-H stretching vibration. The spectral band at 1560 cm⁻¹ includes C=O stretching, vibrations specific to C-N stretching, and N-H deformation, which indicate the –NH–C=O group. The absorption band at 1680–1740 cm⁻¹ represents unionized carboxyl groups, while 1550–1620 cm⁻¹ represents ionized carboxyl groups. The unionized carboxyl group absorption band of FE is at 1716 cm⁻¹, while that of FECa disappears. In addition, the absorption band of FECa at 1569 cm⁻¹ is strengthened, which indicates that calcium could bind the ionized carboxyl group of FE [6, 21, 22].

The UV spectra of FE and FECa are shown in Figures 2(f) and 2(g). The maximum absorption peak of FECa is at 265 nm, but that of FE is not observed, which may be assigned to the changes in the FE constituents induced by the introduction of calcium ions.

The ¹H-NMR spectra of FE and FECa are shown in Figures 2(c) and 2(d). FECa is different from FE. The NMR spectra of FE revealed the presence of obvious signals at δH 3.5–4.2 and 6.3–8.1, according to our previous work in constituents of FE, which might represent some saccharide, flavonoids, and aromatic signals, respectively, while signals of FECa in these two regions are reduced. The overlapping hydrogen signals of FECa at δ_H 1.20–2.40 strengthen, which might indicate that some small molecules, such as organic acids, in FECa are different.

3.4. Body Weight and Biochemical Parameters in Serum

Further functions of FECa in promoting BMD were studied in low-calcium dietary SD rats. After oral administration (as shown in Figure 3(a)), the body weights of the MC group were lower than those of the NC group (). The middle- and high-dose groups were significantly higher than the MC group ().

(a)

(b)

(c)

(d)

Alkaline phosphatase (ALP) is a very well-known marker of bone anabolic activity and a key component of bone metabolism and is expressed early in the development of bone and calcification of cartilage tissues as well as on the cell surface of osteoblasts and in matrix vesicles [23, 24]. Decreased ALP activities (Figure 3(b)) in the serum may indicate that bone formation was inhibited while bone absorption was activated. In this study, ALP activity in the FECa-treated groups increased with increasing concentrations of FECa and showed a dose-response relationship, which indicated that the disrupted balance between bone formation and absorption was modified. In addition, ALP levels were higher in the FE group with respect to FECa-L, FECa-M, FECa-H, and CaCO₃, possibly because some compounds only in FE improved the bioactivity of alkaline phosphatase.

Bone metabolism is an important aspect of skeletal development, homeostasis of serum calcium (Ca) and phosphate (P) levels, and maintenance of haematopoiesis [25–27]. As Figure 3(c) and 3(d) show that the serum p level of SD rats was not significantly changed (). However, the serum Ca level of SD rats fed FECa increased compared with the model group ().

3.5. Bone Biomechanical Parameters

BMD is an important role of human bone strength and can affect the risk of osteoporosis along with other environmental factors [28]. The BMD of the MC group rats was greatly reduced compared with that of the NC group (), which means that the low-calcium model was established successfully (Figure 4(b)). Compared with rats in the MC group, the rats treated with FECa had a higher BMD, which explains the protective effect of FECa on promoting BMD. The dry weight analysis of the femurs (Figure 4(c)) also shows that FECa could convert the bone weight decrease. The femur lengths of the NC group were slightly lengthened than those of the MC group (), while there was no significant difference in CG, CaCO₃, FECa-M, and FECa-H ().

(a)

(b)

(c)

(d)

(e)

(f)

Compared with the MC group, the calcium contents of the femurs in the high-dose group rats were greatly increased by approximately 36% (Figure 4(a), ). These results are consistent with our previous data. Specifically, animals were subjected to a calcium balance study [29–31]. Fractional calcium absorption (ACAR) and calcium retention (ACR) were calculated based on the results from urine and fecal outputs. A higher ACAR in the MC group rats was observed. Generally, when the calcium concentration in the blood is lowered, the secretion of parathyroid hormone (PTH) is increased, which then increases the which then increases the reabsorption of calcium in the kidneys [32]. Compared with the CG and CaCO₃ group, the FECa-M group showed increased ACAR and ACR. Based on the experiments described above, we concluded that FECa could enhance calcium balance in SD rats.

3.6. Femur Hematoxylin-Eosin Staining (H&E) and Computed Tomography (CT) Scan

Femur H&E staining and CT scans of SD rats after administration of FECa were performed. The results (Figure 5) show that the MC group rats had fewer scattered bone trabeculae, while obviously wider and more trabeculae in the FECa groups were observed in a dose-dependent manner. The bone trabeculae of the NC group were intact, regularly arranged and compacted, while trabeculae of the MC group were sparse, thinned, and even broken; the structure was disordered and some fragments appeared. All mentioned situations in the MC group were improved after oral administration of FECa. Additionally, sparse trabeculae of the MC group and compacted trabeculae of the FECa groups are shown in the CT scan.

4. Conclusion

The calcium holding capacity, morphology and elemental composition, characterization, and efficacy in promoting the BMD of FECa were examined in this study. Compared with the MC group, the calcium contents of the femurs were increased by 36%, and net calcium balance was enhanced in rats treated with FECa. Using H&E staining of the femur and CT scans of SD rats, it was shown that the width and number of trabeculae from the FECa groups were obviously enlarged, further indicating a dose-dependent effect. The above results indicated that FECa can be a potential and efficient calcium supplementation agent. The biomechanism of BMD in FECa should be investigated in our future work. Although good solubility and activity on bone mineral density from FECa organic calcium is obtained, there are limitations in this study, such as what kinds of chemical composition and how do they work. These limitations should be further explored. This study provides an idea for the preparation and characterization of calcium-incorporated fermented fruit and its efficacy on bone mineral density in rats [33].

Data Availability

All the data are included in the article.

Ethical Approval

This study was approved by the Ethical Committee of Guizhou Medical University with permission number 2000882.

Conflicts of Interest

All authors state that there are no conflicts of interest.

Authors’ Contributions

Yanfang Yan and Zhongsheng Luo contributed equally to this work.

Acknowledgments

This work was funded by the Science and Technology Projects of Guizhou Province (grant nos. [2018]2800, [2020]1Y148, [2021] General 512, and [2019]2819), Key Laboratory of Characteristic Institution of Higher Education of Guizhou Province (QJHKY [2020]018), Efficient Utilization Engineering Research Center for Natural Products of Guizhou Province (grant no. QCJ [2019]303), Platform for Enhancing Innovation Capacity of R&D and Achievements of Health and Wellness Products from Guizhou edible and medicinal resources (grant no. QKHFQ[2020]4013), and Central and Provincial Special Projects on Agricultural Production Development (the Third Batch of Projects on Rural Industrial Revolution Development of Rosa roxburghii) (grant no. QCC [2019]261).

References

G. Singh and K. Muthukumarappan, “Influence of calcium fortification on sensory, physical and rheological characteristics of fruit yogurt,” Lebensmittel-Wissenschaft und -Technologie- Food Science and Technology, vol. 41, no. 7, pp. 1145–1152, 2008.
View at: Publisher Site | Google Scholar
L. Vannucci, C. Fossi, S. Quattrini et al., “Calcium intake in bone health: a focus on calcium-rich mineral waters,” Nutrients, vol. 10, no. 12, pp. 1930–1942, 2018.
View at: Publisher Site | Google Scholar
M. D. Bootman, T. J. Collins, C. M. Peppiatt et al., “Calcium signalling-an overview,” Seminars in Cell & Developmental Biology, vol. 12, no. 1, pp. 3–10, 2001.
View at: Publisher Site | Google Scholar
M. T. Löffler, N. Sollmann, E. Burian et al., “Opportunistic osteoporosis screening reveals low bone density in patients with screw loosening after lumbar semirigid instrumentation: a case-control study,” Frontiers in Endocrinology, vol. 11, 2021.
View at: Google Scholar
F. Meng, L. Fan, L. Sun, Q. Yu, M. Wang, and C. Sun, “Serum biomarkers of the calcium-deficient rats identified by metabolomics based on UPLC/Q-Tof ms/ms,” Nutrition & Metabolism, vol. 17, p. 1, 2020.
View at: Publisher Site | Google Scholar
Q. Shen, C. Zhang, H. Mo et al., “Fabrication of chondroitin sulfate calcium complex and its chondrocyte proliferation in vitro,” Carbohydrate Polymers, vol. 254, 2021.
View at: Google Scholar
H. Tu, Z. Wang, and I. Bezprozvanny, “Modulation of mammalian inositol 1,4,5-trisphosphate receptor isoforms by calcium: a role of calcium sensor region,” Biophysical Journal, vol. 88, no. 2, pp. 1056–1069, 2005.
View at: Publisher Site | Google Scholar
A. M. Kaunitz, M. R. Mcclung, R. G. Feldman, and S. Wysocki, “Postmenopausal osteoporosis: fracture risk and prevention,” Journal of Family Practice, vol. 58, 2009.
View at: Google Scholar
A. Bitto, F. Polito, B. Burnett et al., “Protective effect of genistein aglycone on the development of osteonecrosis of the femoral head and secondary osteoporosis induced by methylprednisolone in rats,” Journal of Endocrinology, vol. 201, no. 3, pp. 321–328, 2009.
View at: Publisher Site | Google Scholar
Z.-R. Li, L.-M. Cheng, K.-Z. Wang et al., “Herbal Fufang Xian Ling Gu Bao prevents corticosteroid-induced osteonecrosis of the femoral head-A first multicentre, randomised, double-blind, placebo-controlled clinical trial,” Journal of Orthopaedic Translation, vol. 12, pp. 36–44, 2018.
View at: Publisher Site | Google Scholar
L. Wang, B. Zhang, J. Xiao, Q. Huang, C. Li, and X. Fu, “Physicochemical, functional, and biological properties of water-soluble polysaccharides from Rosa roxburghii Tratt fruit,” Food Chemistry, vol. 249, pp. 127–135, 2018.
View at: Publisher Site | Google Scholar
L. Wang, C. Li, Q. Huang, and X. Fu, “Polysaccharide from Rosa roxburghii Tratt fruit attenuates hyperglycemia and hyperlipidemia and regulates colon microbiota in diabetic db/db mice,” Journal of Agricultural and Food Chemistry, vol. 68, no. 1, pp. 147–159, 2020.
View at: Publisher Site | Google Scholar
Q. Guan, T. Xiong, and M. Xie, “Influence of probiotic fermented fruit and vegetables on human health and the related industrial development,” The Trend in Engineering, vol. 11, Article ID 552719, 2020.
View at: Google Scholar
E. M. Selhub, A. C. Logan, and A. C. Bested, “Fermented foods, microbiota, and mental health: ancient practice meets nutritional psychiatry,” Journal of Physiological Anthropology, vol. 33, 2014.
View at: Publisher Site | Google Scholar
M. L. Marco, D. Heeney, S. Binda et al., “Health benefits of fermented foods: microbiota and beyond,” Current Opinion in Biotechnology, vol. 44, pp. 94–102, 2017.
View at: Publisher Site | Google Scholar
F. Chen, L. Li, M. Peng et al., “Identification of triterpenoids and hepatoprotective property of Fructus Rosa roxburghii against alcohol-induced liver injury by regulating keap1- Nrf2 signaling,” Phytomedicine, vol. 1, no. 4, Article ID 100102, 2021.
View at: Publisher Site | Google Scholar
C. F. Diguță, G. D. Nițoi, F. Matei, G. Luță, and C. P. Cornea, “The biotechnological potential of pediococcus spp. isolated from kombucha microbial consortium,” Foods, vol. 9, no. 12, p. 1780, 2020.
View at: Publisher Site | Google Scholar
Y. Zhang, W.-P. Lai, P.-C. Leung, C.-F. Wu, X.-S. Yao, and M.-S. Wong, “Effects of Fructus Ligustri Lucidi extract on bone turnover and calcium balance in ovariectomized rats,” Biological and Pharmaceutical Bulletin, vol. 29, no. 2, pp. 291–296, 2006.
View at: Publisher Site | Google Scholar
K. Adriana and Z. Boris, “Chemical analysis of pollen by FT-Raman and FTIR spectroscopies,” Frontiers of Plant Science, vol. 11, no. 352, 2020.
View at: Google Scholar
Y. Ma, H. Zhou, C. Li et al., “Differential metabolites in Chinese autistic children: a multi-center study based on urinary 1H-NMR metabolomics analysis,” Frontiers in Psychiatry, vol. 12, Article ID 624767, 2021.
View at: Google Scholar
A. P. Tikunov, C. B. Johnson, H. Lee, M. K. Stoskopf, and J. M. Macdonald, “Metabolomic investigations of American Oysters using 1H-NMR spectroscopy,” Marine Drugs, vol. 8, no. 10, pp. 2578–2596, 2010.
View at: Publisher Site | Google Scholar
H. Uchisawa, B.-i. Okuzaki, J. Ichita, and H. Matsue, “Binding between calcium ions and chondroitin sulfate chains of salmon nasal cartilage glycosaminoglycan,” International Congress Series, vol. 1223, pp. 205–220, 2001.
View at: Publisher Site | Google Scholar
L.-F. Wang, S.-S. Shen, and S.-C. Lu, “Synthesis and characterization of chondroitin sulfate-methacrylate hydrogels,” Carbohydrate Polymers, vol. 52, no. 4, pp. 389–396, 2003.
View at: Publisher Site | Google Scholar
L. L. Quezada, S. S. M. Kelinske, and A. Liba, “Bactericidal disruption of magnesium metallostasis in mycobacterium tuberculosis is counteracted by mutations in the metal ion transporter cora,” mBio, vol. 10, no. 4, 2019.
View at: Publisher Site | Google Scholar
Z. Imtiyaz, Y.-F. Wang, Y.-T. Lin, H.-K. Liu, and M.-H. Lee, “Isolated compounds from turpinia formosana nakai induce ossification,” International Journal of Molecular Sciences, vol. 20, no. 13, pp. 3119–3121, 2019.
View at: Publisher Site | Google Scholar
K. Jumpei, H. Kenji, N. Eriko et al., “Interaction of lef1 with taz is necessary for the osteoblastogenic activity of wnt3a,” Scientific Reports, vol. 8, no. 1, pp. 10375–10377, 2018.
View at: Google Scholar
R. Nishimura, K. Hata, T. Matsubara, M. Wakabayashi, and T. Yoneda, “Regulation of bone and cartilage development by network between BMP signalling and transcription factors,” Journal of Biochemistry, vol. 151, no. 3, pp. 247–254, 2012.
View at: Publisher Site | Google Scholar
W. F. Lems, G. J. Van Veen, M. I. Gerrits et al., “Effect of low-dose prednisone (with calcium and calcitriol supplementation) on calcium and bone metabolism in healthy volunteers,” British Journal of Rheumatology, vol. 37, no. 1, 1998.
View at: Publisher Site | Google Scholar
E. E. Golub and K. Boesze-Battaglia, “The role of alkaline phosphatase in mineralization,” Current Opinion in Orthopaedics, vol. 18, no. 5, pp. 444–448, 2007.
View at: Publisher Site | Google Scholar
R. Korstanje, N. Ishimori, I. M. Stylianou et al., “Quantitative trait loci for BMD in an SM/J by NZB/BlNJ intercross population and identification of Trps1 as a probable candidate gene,” Journal of Bone and Mineral Research, vol. 23, no. 9, pp. 1529–1537, 2008.
View at: Google Scholar
W. Tiyasatkulkovit, S. Aksornthong, P. Adulyaritthikul et al., “Excessive salt consumption causes systemic calcium mishandling and worsens microarchitecture and strength of long bones in rats,” Scientific Reports, vol. 11, no. 1, p. 1850, 2021.
View at: Publisher Site | Google Scholar
S. CaO, X.-L. Dong, M.-X. Ho et al., “Oleanolic acid exerts osteoprotective effects and modulates vitamin d metabolism,” Nutrients, vol. 10, no. 2, p. 247, 2018.
View at: Publisher Site | Google Scholar
P. C. Reyes-Fernandez and J. C. Fleet, “Compensatory changes in calcium metabolism accompany the loss of vitamin D receptor (VDR) from the distal intestine and kidney of mice,” Journal of Bone and Mineral Research, vol. 31, no. 1, pp. 143–151, 2016.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2022 Yanfang Yan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

288

Downloads

513

Citations

Evidence-Based Complementary and Alternative Medicine

Preparation and Characterization of Calcium-Incorporated Rosa roxburghii Tratt and Its Efficacy on Bone Mineral Density in Rats

Abstract

1. Introduction

2. Materials and Methods

2.1. Materials

2.2. Preparation of FE and FECa

2.3. Determination of Calcium Holding Capacity

2.4. Characterization of FECa

2.5. FTIR, 1H-NMR, and UV Spectroscopy

2.6. Evaluation of FECa on BMD in SD Rats

2.6.1. Animals and Animal Treatment

2.7. Sample Collection

2.8. Alkaline Phosphatase (ALP), Serum Calcium, and Serum Phosphorus (P) Expression Assay

2.9. Calcium Balance Study

2.10. Femur Condition Detection

2.11. Bone Mineralization Assay

2.12. Histopathology Observation

2.13. Statistical Analysis

3. Results and Discussion

3.1. The Fabrication of FECa

3.2. Morphological Analysis of FECa

3.3. FTIR, 1H-NMR, and UV Spectroscopy

3.4. Body Weight and Biochemical Parameters in Serum

3.5. Bone Biomechanical Parameters

3.6. Femur Hematoxylin-Eosin Staining (H&E) and Computed Tomography (CT) Scan

4. Conclusion

Data Availability

Ethical Approval

Conflicts of Interest

Authors’ Contributions

Acknowledgments

References

Copyright

2.5. FTIR, ¹H-NMR, and UV Spectroscopy

3.3. FTIR, ¹H-NMR, and UV Spectroscopy